Volatility reigned in January on elevated volume as stock investors shifted their focus from global events to U.S. earnings reports, which have ranged from amazing (e.g., Apple) to crushing (e.g., Microsoft). Although the earnings reports have brought plenty of surprises, the volatility is no surprise, as I and many other market commentators predicted for the New Year. Read more about Sector Detector: Volatility continues as earnings reports create excitement and despair

Stocks saw elevated volume and volatility last week, and the 100-day simple moving average on the S&P 500 proved to be the proverbial line-in-the-sand for bullish investors. I opined last week that the market seemed to have sufficiently cycled back down to oversold territory, so with a little more technical consolidation and successful testing of nearby support levels, the next move higher could easily commence at any time. So, the question remains as to whether that was the big new buying opportunity, or whether more backing-and-filling is needed. Read more about Sector Detector: August consolidation offers chance to buy top stocks from top sectors

Scott MartindaleOnce again, stocks have shown some inkling of weakness. But every other time for almost three years running, the bears have failed to pile on and get a real correction in gear. Will this time be different? Read more about Sector Detector: Bold bulls dare meek bears to take another crack

Scott MartindaleThe weakness last week in U.S. stocks was entirely expected. As I mentioned in last weekend’s article, the technical condition had become quite overbought and the market was overdue to take a breather and pull back a bit. Also, our SectorCast rankings had moved from bullish to a more neutral bias. Read more about Sector Detector: Utilities plow ahead while market takes an overdue breather

smartindale / Tag: sectors, iShares, ETF, SPY, VIX, iyw, IYF, IDU, IYH, IYE, IYK, IYC, IYM, IYZ, TDIV, KBWD, PPH, UPW, AXE, FFIV, BOFI, SIVB, ACT, biib / 0 Comments

SPY chartStocks provided a volatile and sweat-inducing ride last week in what many investors and traders thought might be the big selloff that so many have been predicting. Although the market tends to follow a path that fools the greatest number of people, sometimes it behaves in a self-fulfilling prophesy. Read more about Sector Detector: Stock market approaching a crossroads

smartindale / Tag: sectors, iShares, ETF, SPY, VIX, IYF, iyw, IYH, IYK, IYJ, IYC, IYE, IYM, IYZ, IDU, QABA PSI, PPH, PRE, SBNY, FFIV, WDAY, biib, MCK / 0 Comments

Scott MartindaleThere is no sugar-coating what happened to stocks on Friday. All around the world, stocks really took it on the chin as the usual support mechanisms that bulls have enjoyed failed to materialize. The S&P 500 sliced through firm support at 1800 on high volume like it wasn’t even there. But market participants had become convinced that a long-overdue correction was imminent, so they quite simply were looking for a reason to sell. Read more about Sector Detector: Will investors embrace weakness as an entry point?

smartindale / Tag: iShares, sectors, ETF, SPY, VIX, iyw, IYF, IYH, IYJ, IYE, IYM, IYZ, IDU, IYC, IYK, biib, SLXP, IACI, QCOM, SBNY, AMP / 0 Comments

Cancer is a class of diseases in which a group of cells display uncontrolled growth.  Some cancers invade or intrude upon adjacent tissues, then destroy that tissue/organ, and then spread (metastasize) to other locations in the body via lymph or blood.  These three malignant properties of cancers differentiate them from benign tumors, which do not invade or metastasize.  All of these diseases suggest that there will be a need for personalized therapy, as even within a specific type of cancer, there is wide heterogeneity in clinicopathological features.  For instance, leukemia, lymphoma, mye Read more about Another Immune Company Play - Immunomedics

ilene / Tag: biib, imgn, immu, Sabrient / 0 Comments